Search Results - "Dirchwolf, M"

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them by Marciano, S., Dirchwolf, M., Torres, M.C., Allevato, J., García Dans, C., García, B., Pollarsky, F., Gaite, L., Sirotinsky, E., Rios, B., Anselmo, M.N., Peche, M., Hurtado, E., Haddad, L., Narvaez, A., Mauro, E., Martinez, A., Bellizzi, C., Ratusnu, N., D’Amico, C., Arora, S., Gadano, A.

“…Fibrosis staging in patients with nonalcoholic fatty liver disease (NAFLD) is carried out through the application of stepwise algorithms but there is little…”
Get full text

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them by Marciano, S, Dirchwolf, M, Torres, M C, Allevato, J, García Dans, C, García, B, Pollarsky, F, Gaite, L, Sirotinsky, E, Rios, B, Anselmo, M N, Peche, M, Hurtado, E, Haddad, L, Narvaez, A, Mauro, E, Martinez, A, Bellizzi, C, Ratusnu, N, D Amico, C, Arora, S, Gadano, A

“…Fibrosis staging in patients with nonalcoholic fatty liver disease (NAFLD) is carried out through the application of stepwise algorithms but there is little…”
Get full text

1328 NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN PATIENTS: IDENTIFYING HIDDEN CULPRITS by Dirchwolf, M, Zunino, M, Tauterys, M, Paz, S, Estepo, C, Schroder, T, Fainboim, H

Get full text

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources by Marciano, S, Haddad, L, Borzi, S M, D'Amico, C, Gaite, L A, Aubone, M V, Sirotinsky, M E, Ratusnu, N, Frola, M S, Aparicio, M C, Ríos, B, Anselmo, M N, Hansen, R, De Filippi, S, Dans, C García, de Labra, L, Peche, M A, Strella, T M, Ibáñez Duran, M, García Rosales, M B, Dirchwolf, M, Galdame, O A, Gadano, A C

“…To estimate the proportion of patients who access to direct-acting antivirals agents (DAAs) for the treatment of hepatitisC in Argentina and to evaluate…”
Get full text

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources by Marciano, S., Haddad, L., Borzi, S.M., D’Amico, C., Gaite, L.A., Aubone, M.V., Sirotinsky, M.E., Ratusnu, N., Frola, M.S., Aparicio, M.C., Ríos, B., Anselmo, M.N., Hansen, R., De Filippi, S., García Dans, C., de Labra, L., Peche, M.A., Strella, T.M., Ibáñez Duran, M., García Rosales, M.B., Dirchwolf, M., Galdame, O.A., Gadano, A.C.

“…To estimate the number of patients that have access to treatment of hepatitis C with direct-acting antivirals in Argentina and evaluate the factors associated…”
Get full text

Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellos by Marciano, S., Dirchwolf, M., Torres, M.C., Allevato, J., García Dans, C., García, B., Pollarsky, F., Gaite, L., Sirotinsky, E., Rios, B., Anselmo, M.N., Peche, M., Hurtado, E., Haddad, L., Narvaez, A., Mauro, E., Martinez, A., Bellizzi, C., Ratusnu, N., D́Amico, C., Arora, S., Gadano, A.

“…La estadificación de la fibrosis en pacientes con enfermedad por hígado graso no alcohólico (EHGNA) se realiza aplicando distintos algoritmos. Sin embargo, hay…”
Get full text

Modelling of the effects of environmental factors on rice grain discoloration incidence in Corrientes province, Argentina by Dirchwolf, Pamela M., Moschini, Ricardo C., Gutiérrez, Susana A., Carmona, Marcelo A.

“…Rice grain discoloration (RGD) is a disease of complex aetiology for which there are no resistant varieties. Due to the need to better define the environmental…”
Get full text

Evaluación del acceso a antivirales para el tratamiento de la hepatitis C en un país con recursos limitados by Marciano, S, Haddad, L, Borzi, S.M, D’Amico, C, Gaite, L.A, Aubone, M.V, Sirotinsky, M.E, Ratusnu, N, Frola, M.S, Aparicio, M.C, Ríos, B, Anselmo, M.N, Hansen, R, De Filippi, S, Dans, C. García, de Labra, L, Peche, M.A, Strella, T.M, Ibáñez Duran, M, García Rosales, M.B, Dirchwolf, M, Galdame, O.A, Gadano, A.C

“…Resumen Objetivos Estimar la proporción de pacientes que acceden al tratamiento de la hepatitis C con antivirales de acción directa (AAD) en Argentina, y…”
Get full text

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies by Marciano, Sebastián, Díaz, Juan Manuel, Dirchwolf, Melisa, Gadano, Adrián

“…Spontaneous bacterial peritonitis is the most frequent bacterial infection in patients with cirrhosis. The reported incidence varies between 7% and 30% in…”
Get full text

Pre-treatment prediction of response to peginterferon plusribavirin in chronic hepatitis C genotype 3 by Sebastián Marciano Silvia M Borzi Melisa Dirchwolf Ezequiel Ridruejo Manuel Mendizabal Fernando Bessone María E Sirotinsky Diego H Giunta Julieta Trinks Pablo A Olivera Omar A Galdame Marcelo OSilva Hugo A Fainboim Adrián C Gadano

“…AIM： To evaluate pre-treatment factors associatedwith sustained virological response （SVR） in patientswith hepatitis C virus （HCV） genotype 3 treated…”
Get full text